Recombinant Xenopus tropicalis Serine/Threonine-Protein Kinase Greatwall (MASTL), partial, refers to a truncated, laboratory-engineered form of the Greatwall kinase protein derived from the Western clawed frog (Xenopus tropicalis). This recombinant variant retains critical functional domains required for its enzymatic activity and regulatory roles in mitosis. MASTL is a member of the AGC kinase family and plays a pivotal role in maintaining mitotic progression by inhibiting Protein Phosphatase 2A (PP2A)-B55 complexes through phosphorylation of its substrates, ARPP19 and α-endosulfine (ENSA) .
Catalytic Function: Phosphorylates ARPP19/ENSA to inhibit PP2A-B55, stabilizing mitotic phosphorylations driven by Cyclin B-CDK1 .
Structural Motifs: Contains a non-conserved middle region (NCMR) of ~550 residues within its activation loop, unique to MASTL orthologs .
Regulatory Sites: Critical phosphorylation sites (e.g., Ser875 in humans) are essential for kinase activity and mitotic regulation .
MASTL ensures proper mitotic progression by counteracting PP2A-B55 phosphatase activity, which is crucial for dephosphorylating CDK1 substrates. Studies in Xenopus egg extracts highlight its dual role:
Mitotic Entry: Active MASTL accelerates G2/M transition by promoting CDK1 activation via Cdc25 phosphatase regulation .
Mitotic Maintenance: Prevents premature mitotic exit by sustaining CDK1 substrate phosphorylation .
Depletion of MASTL in Xenopus extracts leads to mitotic collapse due to PP2A-B55 reactivation, causing defective chromosome condensation and SAC activation .
MASTL activity is regulated by CDK1-dependent phosphorylation, forming a feedback loop essential for mitotic fidelity .
Recombinant MASTL variants are pivotal in dissecting mitotic mechanisms and therapeutic targeting:
MASTL overexpression is linked to cancer progression (e.g., breast cancer), where it enhances chemotherapy resistance and genomic instability . Conversely, MASTL inhibition sensitizes tumors to genotoxic agents, highlighting its potential as a therapeutic target .
Greatwall kinase, encoded by the mastl gene (NM_001127074.1) in Xenopus tropicalis, is a serine/threonine protein kinase belonging to the AGC family of kinases. It serves as a critical regulator of mitotic entry and maintenance by indirectly inhibiting protein phosphatase 2A (PP2A) with the B55 regulatory subunit (PP2A-B55) . During mitosis, Greatwall phosphorylates downstream substrates including endosulfine (ENSA) and cAMP-regulated phosphoprotein 19 (Arpp19), which then bind to and inhibit PP2A-B55, the principal phosphatase for Cdk-phosphorylated substrates . This inhibition creates a permissive environment for Cdk1-driven mitotic phosphorylation events to accumulate, enabling proper mitotic progression.
While Greatwall kinase serves similar functions in both Xenopus species, studying the protein in Xenopus tropicalis offers distinct advantages. Xenopus tropicalis possesses a diploid genome (unlike the pseudotetraploid X. laevis) and has a shorter generation time, making it more suitable for genetic studies . The Xenopus tropicalis mastl gene produces a protein that maintains the core functional domains and regulatory sites found in X. laevis Greatwall, but differences in sequence may affect antibody recognition and potentially protein-protein interactions. For research requiring genetic manipulation and multi-generational studies, X. tropicalis offers significant advantages despite its smaller eggs and embryos compared to X. laevis .
Greatwall kinase functions within an autoregulatory loop with maturation promoting factor (MPF, composed of cyclin B and Cdk1) during mitosis . Experimental evidence demonstrates that:
Greatwall is activated during mitosis through phosphorylation, with MPF serving as an upstream kinase
Depletion of Greatwall from mitotic extracts rapidly reduces MPF activity due to accumulation of inhibitory phosphorylations on Cdk1
Greatwall depletion prevents cycling extracts from entering M phase
The effects of Greatwall depletion can be rescued by adding either wild-type Greatwall or a non-inhibitable form of Cdk1 kinase
In G2 phase oocytes, Greatwall binds to active PP2A/B55 but dissociates from it when progesterone-treated oocytes reach M phase . This spatial and temporal regulation of Greatwall is essential for proper mitotic timing and completion.
For recombinant expression of Xenopus tropicalis Greatwall kinase, researchers should consider the following methodological approach:
cDNA Clone Selection: Utilize expression-ready ORF clones based on the NM_001127074.1 accession . Select a vector system compatible with your expression needs (prokaryotic vs. eukaryotic expression).
Expression Systems:
For biochemical characterization: Baculovirus-insect cell expression systems are preferred as they maintain proper post-translational modifications
For structural studies: E. coli expression systems may be used for protein domains, though full-length protein often requires eukaryotic expression
For cellular studies: Mammalian expression systems using CMV or other strong promoters
Purification Strategy:
Incorporate affinity tags (His6, FLAG, or GST) for simplified purification
Include a TEV protease cleavage site to remove tags if necessary for activity assays
Employ size exclusion chromatography as a final purification step to ensure homogeneity
Protein Stabilization:
Add phosphatase inhibitors during purification to maintain phosphorylation status
Consider co-expression with interacting partners for stability
Optimize buffer conditions (pH 7.5-8.0, with 10-15% glycerol) for long-term storage
Transgenic Xenopus tropicalis expressing modified Greatwall kinase can be generated using restriction enzyme mediated integration (REMI), which involves three primary steps :
Preparation of High-Speed Egg Extracts:
These extracts facilitate replacement of protamines in sperm nuclei with nucleosomes
The extracts decondense chromatin of sperm nuclei to prepare for DNA integration
Sperm Nuclei Isolation:
Isolate high-quality sperm nuclei from male X. tropicalis using established protocols
Maintain nuclei in sperm dilution buffer to preserve integrity
Nuclear Transplantation:
For mastl-specific modifications, design your construct with:
Tissue-specific or inducible promoters for controlled expression
Fluorescent tags (C-terminal preferred to avoid disrupting kinase function)
Point mutations of interest (e.g., phosphorylation sites or catalytic residues)
Several monoclonal antibodies have been developed specifically for Xenopus Greatwall kinase that are applicable for multiple experimental techniques :
| Antibody Type | Applications | Cross-reactivity | Notes |
|---|---|---|---|
| Mouse monoclonal antibodies | Immunoblotting, Immunoprecipitation, Immunodepletion | Xenopus-specific | Panel of antibodies available |
| Neutralizing antibody | Functional inhibition in egg extracts | Xenopus Gwl | Causes loss of mitotic phosphorylation of Gwl, Plk1, and Cdk1 substrates |
| Cross-reactive antibodies | Western blotting | Human MASTL | Useful for comparative studies |
When selecting antibodies, consider:
The specific epitope recognized (N-terminal vs. C-terminal vs. phospho-specific)
The experimental application (Western blotting typically requires different antibodies than immunoprecipitation)
Whether functional inhibition or simple detection is required
Greatwall kinase plays a critical role in maintaining the spindle assembly checkpoint (SAC) through regulation of protein phosphorylation states:
MPS1 Regulation: Mastl is required for multi-site phosphorylation of MPS1, an essential SAC kinase, as well as for robust MPS1 kinase activity in mitosis .
PP2A/B55 Inhibition Mechanism: Mastl promotes persistent MPS1 phosphorylation by inhibiting PP2A/B55-mediated MPS1 dephosphorylation rather than by directly affecting Cdk1 kinase activity .
Experimental Evidence:
Mastl knockout (Mastl NULL) MEFs show premature disappearance of the essential SAC protein Mad1 at kinetochores
The duration of mitotic arrest caused by microtubule poisons in Mastl NULL MEFs is shortened
Treatment with the phosphatase inhibitor okadaic acid (OKA) rescues defects in MPS1 kinase activity, mislocalization of phospho-MPS1 and Mad1 at the kinetochore, and premature SAC silencing
This suggests a model wherein Greatwall→Arpp19/ENSA→PP2A/B55 inhibition pathway is essential for maintaining SAC through regulation of MPS1 phosphorylation status.
Greatwall kinase establishes a regulatory network with protein phosphatases that is essential for proper mitotic progression:
PP2A/B55 Regulation: In G2 phase, Greatwall binds active PP2A/B55 but dissociates upon entry into M phase . This dissociation does not require Greatwall kinase activity or phosphorylation at T748 in the presumptive T loop of the kinase.
Mechanism of Inhibition: Greatwall phosphorylates two small proteins, Arpp19 and ENSA, which then bind to and inhibit PP2A/B55 . This inhibition creates a dominant kinase environment required for mitotic entry and maintenance.
Feedback Loop: The relationship forms a regulatory circuit:
Cdk1 activation leads to Greatwall activation
Activated Greatwall phosphorylates Arpp19/ENSA
Phosphorylated Arpp19/ENSA inhibit PP2A/B55
Inhibited PP2A/B55 cannot dephosphorylate Cdk1 substrates
This maintains high Cdk1 activity and keeps Greatwall active
Temporal Regulation: This system ensures switch-like transitions between interphase and mitosis, preventing inappropriate partial activation of mitotic processes.
To investigate the effects of Greatwall mutations in Xenopus tropicalis, researchers can employ several complementary approaches:
CRISPR/Cas9 Genome Editing:
Design guide RNAs targeting specific regions of the mastl gene
Introduce donor templates for precise mutations or gene replacements
Screen F0 founders for germline transmission of the mutation
Morpholino Knockdown Combined with Rescue:
Design morpholinos targeting endogenous mastl mRNA
Co-inject morpholinos with mRNA encoding mutant versions of Greatwall
This approach allows analysis of specific mutations in a knockdown background
Dominant-Negative Approaches:
Xenopus Egg Extract System:
Immunodeplete endogenous Greatwall from egg extracts
Add back recombinant wild-type or mutant Greatwall protein
Measure effects on downstream pathways and mitotic progression
For analyzing the K71M (Scant) mutation specifically, note that despite having reduced stability and elevated degradation by the proteasome, this mutant induces M phase in the absence of progesterone when expressed in oocytes .
The activity and localization of Xenopus tropicalis Greatwall kinase is regulated by multiple phosphorylation events:
| Phosphorylation Site | Kinase Responsible | Function | Conservation |
|---|---|---|---|
| T748 (presumptive T-loop) | Cdk1 (putative) | Activation of kinase activity | Conserved across species |
| S875 | Cdk1 | Required for full activation | Conserved in vertebrates |
| Multiple N-terminal sites | Cdk1 | Regulation of protein interactions | Variable conservation |
Key findings regarding phosphorylation:
Greatwall dissociation from PP2A/B55 when progesterone-treated oocytes reach M phase does not require phosphorylation at T748 in the presumptive T loop of the kinase
Greatwall is activated during mitosis by phosphorylation, with evidence indicating that maturation promoting factor (MPF) is an upstream kinase
The phosphorylation status affects Greatwall's ability to phosphorylate downstream targets including endosulfine and Arpp19
Greatwall kinase shows evolutionary conservation with functional specialization across species:
| Species | Gene Name | Key Features | Functional Similarities/Differences |
|---|---|---|---|
| Xenopus tropicalis | mastl | Regulates mitotic entry and maintenance | Core function in PP2A/B55 regulation via Arpp19/ENSA |
| Mammals | MASTL | Essential for mitosis | Knockout causes embryonic lethality; similar mechanism of PP2A/B55 regulation |
| Drosophila | Greatwall | First identified in mutant screens | Required for proper condensation and segregation of chromosomes |
| Budding yeast | Rim15 | Nutrient-responsive kinase | Diverged role in stress response and quiescence |
| Fission yeast | Ppk18 | Cell size regulator | Controls cell cycle entry in response to nutrients |
The Greatwall–Arpp19–ENSA–PP2A-B55 pathway plays an essential role in the control of M and S phases from yeast to human, though with species-specific adaptations . The mammalian ortholog MASTL is required for embryonic development and proper cell division, as Mastl knockout (MastlNULL/NULL) mice die within 7–8 days while heterozygous Mastl+/NULL mice remain viable with no visible phenotypical abnormalities .
When working with recombinant Xenopus tropicalis Greatwall kinase, researchers commonly encounter several technical challenges:
Protein Solubility Issues:
Problem: Insoluble protein expression or aggregation during purification
Solution: Express with solubility tags (MBP, SUMO); optimize buffer conditions with increased salt (150-300mM NaCl) and mild detergents (0.01% NP-40)
Low Kinase Activity:
Problem: Purified protein shows minimal catalytic activity
Solution: Ensure proper phosphorylation status by co-expressing with Cdk1/Cyclin B; add phosphatase inhibitors throughout purification; confirm protein folding by circular dichroism
Protein Degradation:
Problem: Rapid degradation during expression or storage
Solution: Include protease inhibitor cocktails; express at lower temperatures (16-18°C); store with 15% glycerol at -80°C in small aliquots
Expression Level Variations:
Problem: Inconsistent yield between expression batches
Solution: Standardize induction conditions; optimize codon usage for expression system; consider stable cell line development for consistent expression
Preserving Post-translational Modifications:
Problem: Loss of critical phosphorylation during purification
Solution: Include phosphatase inhibitors (PhosSTOP); perform purification steps rapidly at 4°C; validate phosphorylation status by phospho-specific antibodies or mass spectrometry
To effectively study the interactions between Greatwall kinase and PP2A/B55, consider these methodological approaches:
Co-immunoprecipitation Studies:
Use antibodies against Greatwall to precipitate protein complexes from Xenopus egg extracts in different cell cycle states
Analyze by Western blotting for PP2A subunits (catalytic C, scaffolding A, and regulatory B55)
Compare interacting proteins in interphase versus mitotic extracts
Proximity Ligation Assays in Xenopus Cells:
Detect protein-protein interactions in situ
Visualize spatial and temporal dynamics of interactions
Quantify interaction frequency under different conditions
Fluorescence Resonance Energy Transfer (FRET):
Generate fluorescently tagged Greatwall and PP2A/B55 constructs
Express in Xenopus cells or inject mRNA into embryos
Measure interaction dynamics in real-time during cell cycle progression
In vitro Reconstitution Assays:
Purify recombinant Greatwall (wild-type and mutants)
Isolate PP2A/B55 from Xenopus egg extracts or use recombinant components
Assess direct binding through pull-down assays
Measure effects of Arpp19/ENSA on complex formation
Analytical Approaches:
Surface Plasmon Resonance (SPR) to measure binding kinetics
Isothermal Titration Calorimetry (ITC) to determine binding thermodynamics
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS) to map binding interfaces
Evidence shows that Greatwall binds active PP2A/B55 in G2 phase oocytes but dissociates when progesterone-treated oocytes reach M phase, and this dissociation does not require Greatwall kinase activity or phosphorylation at T748 .
When studying Greatwall kinase activity in Xenopus egg extracts, include these essential controls:
Depletion Controls:
Mock-depleted extracts (using non-specific IgG)
Extracts depleted of Greatwall and rescued with recombinant wild-type protein
Extracts depleted of Greatwall and rescued with kinase-dead mutant
Cell Cycle State Verification:
Histone H1 kinase assay to confirm MPF activity
Western blotting for cyclin B levels
Microscopic examination of chromatin morphology in extracts supplemented with sperm nuclei
Phosphatase Inhibition Controls:
Addition of okadaic acid at specific concentrations to inhibit PP2A
Comparison of phenotypes between Greatwall depletion and phosphatase inhibition
Combined treatments to determine epistatic relationships
Substrate Specificity Controls:
Parallel kinase assays with known Greatwall substrates (Arpp19, ENSA)
Assays with mutated substrate proteins lacking key phosphorylation sites
Competition assays with phosphomimetic substrate variants
Temporal Controls:
Time-course experiments to track kinase activity through cell cycle progression
Synchronization controls using cell cycle inhibitors (e.g., roscovitine for Cdk inhibition)
Research has demonstrated that the addition of neutralizing antibody into M-phase extracts results in loss of mitotic phosphorylation of Greatwall, Plk1, and Cdk1 substrates , providing a useful tool for functional inhibition.